Return to homepagePandemic Pact

Analysis of Antibody Neutralization Efficiency, Seroprevalence and Long Term Immunity in SARS-CoV-2-Positive Individuals Identified in a Surveillance Survey of At-Risk Individuals

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 202012GSM

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $13,125

  • Funder

    Canadian Institutes of Health Research (CIHR)

  • Principal Investigator

    N/A

  • Research Location

    Canada

  • Lead Research Institution

    University of Ottawa

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Vulnerable populations unspecified

  • Occupations of Interest

    Unspecified

Abstract